
DIADEMA PARTNERS LP
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | ROIV | 120K | $1.82M |
![]() | MNMD | 106K | $1.25M |
![]() | AMLX | 100K | $1.36M |
![]() | COGT | 98K | $1.40M |
![]() | URGN | 90K | $1.80M |
![]() | TRVI | 86K | $785.35K |
![]() | NKTR | 75K | $4.27M |
![]() | XERS | 75K | $608.49K |
![]() | ALKS | 72K | $2.16M |
![]() | VTYX | 71K | $221.44K |
![]() | APGE | 64K | $2.55M |
![]() | TGTX | 61K | $2.19M |
![]() | RVMD | 59K | $2.76M |
![]() | PCRX | 59K | $1.52M |
![]() | PTGX | 51K | $3.40M |
![]() | FHTX | 50K | $244.50K |
![]() | HRMY | 50K | $1.38M |
![]() | CPRX | 50K | $985.00K |
![]() | ARCT | 49K | $899.59K |
![]() | RLAY | 44K | $227.68K |

Roivant Sciences Ltd.
ROIV
Shares Held
120K
Value
$1.82M

Mind Medicine (MindMed) Inc.
MNMD
Shares Held
106K
Value
$1.25M

Amylyx Pharmaceuticals, Inc.
AMLX
Shares Held
100K
Value
$1.36M

Cogent Biosciences, Inc.
COGT
Shares Held
98K
Value
$1.40M

UroGen Pharma Ltd.
URGN
Shares Held
90K
Value
$1.80M

Trevi Therapeutics, Inc.
TRVI
Shares Held
86K
Value
$785.35K

Nektar Therapeutics
NKTR
Shares Held
75K
Value
$4.27M

Xeris Biopharma Holdings, Inc.
XERS
Shares Held
75K
Value
$608.49K

Alkermes plc
ALKS
Shares Held
72K
Value
$2.16M

Ventyx Biosciences, Inc.
VTYX
Shares Held
71K
Value
$221.44K

Apogee Therapeutics, Inc.
APGE
Shares Held
64K
Value
$2.55M

TG Therapeutics, Inc.
TGTX
Shares Held
61K
Value
$2.19M

Revolution Medicines, Inc.
RVMD
Shares Held
59K
Value
$2.76M

Pacira BioSciences, Inc.
PCRX
Shares Held
59K
Value
$1.52M

Protagonist Therapeutics, Inc.
PTGX
Shares Held
51K
Value
$3.40M

Foghorn Therapeutics Inc.
FHTX
Shares Held
50K
Value
$244.50K

Harmony Biosciences Holdings, Inc.
HRMY
Shares Held
50K
Value
$1.38M

Catalyst Pharmaceuticals, Inc.
CPRX
Shares Held
50K
Value
$985.00K

Arcturus Therapeutics Holdings Inc.
ARCT
Shares Held
49K
Value
$899.59K

Relay Therapeutics, Inc.
RLAY
Shares Held
44K
Value
$227.68K
